A group of researchers sought to examine the physical functioning of patients with breast cancer, in various age brackets, who were enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) phase III trial.
A post-hoc analysis of the Phase 3 ASPIRE study indicates that treatment combining carfilzomib with lenalidomide and dexamethasone extended survival time for patients with multiple myeloma.
Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.
Patients whose treatment was based on the molecular characteristics of their particular tumor had significantly better outcomes compared with patients who did not.
A study examined the relation between various forms of breast cancer therapies and risk of congestive heart failure.
Patients with classical Hodgkin lymphoma who are resistant to the CD30-directed antibody-drug conjugate brentuximab vedotin have poor outcomes.
High neutrophil to lymphocyte ratio (NLR) is linked to worse prognosis in Caucasian patients with early breast cancer.
Researchers have noted a link between supportive care and reduced risk of adverse outcomes.
An exercise intervention did not improve physical functioning for women living with advanced breast cancer, according to a study.
African-American pediatric patients with Hodgkin lymphoma still display a considerable survival disparity when compared to their white and Hispanic peers.
Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.
Ob-gyns report external examinations are important for cancer detection and lesion identification.
Improved survival for patients treated by higher-volume radiation oncologists was observed.
Nipple-sparing Mastectomy Offers Better Cosmetic and Psychological Outcomes for Patients With Breast CancerDecember 09, 2015
Nipple-sparing mastectomy and immediate breast reconstruction results in higher reported patient body image, when compared to skin-sparing partial mastectomy (SS-PM), and may lower risk of local recurrence.
Despite growing popularity of patient navigation (PN) in cancer care, few studies have evaluated the impact of PN on patient outcomes.
A new study found that prognosis after treatment for women with breast cancer with a family history of the disease is no worse than it is for other women with breast cancer.
Higher mortality is associated with more narrow margins for high-risk primary melanoma, per research presented at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting in Chicago.
No difference seen in distant disease-free intervals for those with versus those without a positive family history, say researchers.
Current unemployment for head and neck cancer survivors linked to harder physical work, surgical treatment, and risky alcohol consumption.
Improved rates of stage-specific treatment for early- and advanced-stage non-small-cell lung cancer (NSCLC) with comorbid COPD were linked to a pulmonologist's management.
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.
A new study has better established the future risk of developing breast cancer for those with atypical hyperplasia of the breast.
A new test may reveal which patients will respond to treatment for graft-versus-host disease (GVHD), a serious complication that can arise from stem cell SCT.
According to results of a new, retrospective study, the risk of developing leukemia after radiation therapy or chemotherapy for early stage breast cancer is double that previously reported.
The Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgery (ESTS) plan to link their outcomes data on chest procedures, in an effort to improve patient care.
The long-term survival rates following laparoscopic surgery for bladder cancer are not unlike survival rates for open surgery, according to research.
Trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients, according to a large national study.
Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
- Clinician Communication, Adherence to Protocols, and Presence of Pharmacists Improve Outcomes in ICUs
- Transforming the Care of Patients With Thyroid Cancer
- Immunotherapy Combination is Effective in Colorectal Cancer
- Comprehensive Mental Health Screening Recommended for Some Childhood Cancer Survivors
- Blood Biomarker Is Predictive of Risk for Colon Cancer Recurrence
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Cancer-related Neuropathy May Respond to Gene Therapy
- Tyrosine Kinase Inhibitor Therapy Can Be Safely Stopped in Select Patients With CML in Chronic Phase
- Systematic Palliative Care Provides Greater Improvement in Quality of Life for Patients with Pancreatic Cancer
- Adjuvant Therapy Improves Survival in Stage II Colon Cancer, Study Confirms
- Hybrid Immune Cells Have Antitumor Effects in Early Stage Lung Cancer
- Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|